| October 13, 2025 | Tender Offer results | |||
| July 29, 2025 | Zydus announces completion of the acquisition of an 85.6% stake in Amplitude Surgical and upcoming filing of a simplified tender offer | |||
| July 29, 2025 | Amplitude Surgical – Suspension of listing | |||
| July 24, 2025 | ||||
| April 25, 2025 | Zydus Lifesciences Limited signs purchase agreement with PAI Partners and other shareholders to acquire a majority stake in Amplitude Surgical SA | |||
| April 17, 2025 | Amplitude Surgical - 9-months consolidated sales for FY 2024-25 of €83.8m, up +6.4% at constant exchange rates | |||
| April 17, 2025 | ||||
| March 26, 2025 |
Amplitude Surgical announces H1 2024-25 results: €51.5m sales and €13.1m EBITDA |
|||
| March 11, 2025 | Zydus enters exclusive negotiations with PAI Partners and other shareholders to acquire a majority stake in Amplitude Surgical, France | |||
| February 20, 2025 | Amplitude Surgical - 1st half-year 2024-25: consolidated sales of €51.5m, +6.3% at constant exchange rates |
| November 23, 2023 | ||||
| November 23, 2023 | Amplitude Surgical announces its 2023-24 financial calendar | |||
| October 18, 2023 |
Amplitude Surgical – 2022-23 annual results: Sales of €100.2 million and EBITDA of €26.1 million |
|||
| July 20, 2023 |
Amplitude Surgical - Consolidated annual sales of €100.2m, up +14.0% at constant exchange rates |
|||
| June 29, 2023 | Amplitude Surgical announces the closing of the sale of Novastep's activities | |||
| April 20, 2023 | Amplitude Surgical – H3 2022-23: Consolidated sales of €75.4 million, +15.8% at constant exchange rates | |||
| April 3, 2023 | Amplitude Surgical announces the signing of a definitive agreement for the sale of Novastep's activities | |||
| March 22, 2023 | ||||
| February 23, 2023 | Amplitude Surgical – H1 2022-23: Consolidated sales of €45.2 million, +10.8% at constant exchange rates |
| November 24, 2022 | Amplitude Surgical – First quarter 2022-23: consolidated sales of €19.4 million, +11.3% at constant exchange rates | ||
| November 24, 2022 | Amplitude Surgical announces its 2022-23 financial calendar | ||
| October 19, 2022 |
Amplitude Surgical – 2021-22 annual results: Sales of €87.6m and EBITDA of €22.0m |
||
| July 21, 2022 |
Amplitude Surgical – consolidated annual sales of €104.8 million, up 8.2% at constant exchange rates |
||
| June 28, 2022 | Amplitude Surgical – Launch of a strategic review of Novastep’s foot and ankle activities | ||
| April 26, 2022 | |||
| April 21, 2022 |
Amplitude Surgical – Consolidated 9-month sales of €77.3 million, up 4.0% at constant exchange rates |
||
| March 23, 2022 | Amplitude Surgical announces its results for the first half of 2021-22 | ||
| February 17, 2022 |
Amplitude Surgical – H1 2021-22: Sales of €48.1m, +3.9% at constant exchange rates |
||
| November 18, 2021 |
Amplitude Surgical – First quarter 2021-22: Sales of €20.2 million, -7.1% at constant exchange rates |
||
| November 18, 2021 | |||
| October 20, 2021 | Amplitude Surgical – 2020-21 annual results: sales of €95.5m and EBITDA of €20.6m | ||
| July 22, 2021 |
Amplitude Surgical – consolidated annual sales of €95.5 million, +10% at constant exchange rates |
||
| April 22, 2021 | |||
| March 24, 2021 | Amplitude Surgical – Limited decline in operating performances in H1 2020-21 | ||
| February 18, 2021 |
Amplitude Surgical – H1 2020-21: Sales down 5.3% at constant exchange rates |
||
| November 28, 2019 | Amplitude Surgical - Ordinary and extraordinary Shareholders’ Meeting of December 19, 2019 | ||
| November 21, 2019 |
Amplitude Surgical – First quarter 2019-20: Sales growth of 6.0% at constant exchange rates |
||
| November 21, 2019 | |||
| October 23, 2019 | Amplitude Surgical – 2018-19 annual results: €102.6m sales and 21% EBITDA | ||
| July 25, 2019 | Amplitude Surgical - 2018-19 annual sales of €102.6 million, up +3.0% at constant exchange rates | ||
| July 19, 2019 | Amplitude Surgical - Half-year report on liquidity contract | ||
| April 25, 2019 | Amplitude Surgical - further positive momentum in Q3, 9-month sales of €76.6 million, +5% at constant exchange rates | ||
| March 27, 2019 | Amplitude Surgical – Good operational performances in H1 2018-19 | ||
|
February 1, 2019 |
Amplitude Surgical – H1 2018-19 sales of €47 million, +7.0% – Strong organic growth in Q2, +5% |
||
|
January 25, 2019 |
|||
| November 28, 2018 | Amplitude Surgical - Ordinary and extraordinary Shareholders Meeting of décember 20, 2018 | ||
| November 22, 2018 | Amplitude Surgical - First quarter 2018-19 Strong sales growth of 10.1% | ||
| November 19, 2018 | Amplitude Surgical announces its 2018-19 financial calendarannounces its 2018-19 financial calendar | ||
| October 17, 2018 | Amplitude Surgical – 2017-18 annual results: sales of over €100 million, up +8% like-for-like, and solid EBITDA growth of +17% | ||
| October 15, 2018 | Amplitude Surgical: Mrs. Muriel Benedetto is appointed to the newly-created position of COO | ||
| September 10, 2018 | |||
| July 26, 2018 | 2017-18: a year of achievement | ||
| May 18, 2018 | Amplitude Surgical granted the Euronext Tech 40 label | ||
| April 26, 2018 | Amplitude Surgical: further solid momentum in Q3, 9-month sales of €74m, +6% and +8% at constant currency | ||
| March 28, 2018 | |||
| February 22, 2018 | Amplitude Surgical: further strong organic growth in Q2, +10% - H1 2017-18 sales of €45 million, +8% | ||
